RVN / BTC

ARPA / BTC

ASTR / BTC

THE / USDT

THE / TRY

THE / USDC

BB / BNB

PUMP / TRY

BB / USDT

PUMP / USDT

SPK / FDUSD

TST / USDT

TST / USDC

TST / TRY

DATA / BTC

SPK / BNB

KMNO / USDT

KMNO / USDC

PEOPLE / BTC

NIL / BNB

URBAN COMPANY LIMITED

QMS MEDI LTD

SMARTEN POWER SYSTEMS LTD

TRF LIMITED

SUPERHOUSE LIMITED

IRM ENERGY LIMITED

BRAND CONCEPTS LIMITED

N R VANDANA TEX IND LTD

ANLON HEALTHCARE LIMITED

PROZONE REALTY LIMITED

DE NEERS TOOLS LIMITED

HAPPY SQUARE OUTSOURC S L

ENFUSE SOLUTIONS LIMITED

SHRADHA INFRAPROJECTS LTD

MANGAL ELECTRICAL IND L

SHARP CHUCKS N MACHINES L

ZODIAC CLOTHING CO. LTD.

NAGREEKA EXPORTS LTD.

SHREE RAMA NEWSPRINT LTD

SARVESHWAR FOODS LIMITED

Click here to get full coverage on Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease - Nature

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease  Nature

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease - Nature

Click here to get full coverage on Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study - BioMed Central

Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study  BioMed Central

Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study - BioMed Central

Click here to get full coverage on European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC  OncLive

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

Click here to get full coverage on ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study - UroToday

ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study  UroToday

ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study - UroToday

Click here to get full coverage on Impact of Linker Composition on VHL PROTAC Cell Permeability - ACS Publications

Impact of Linker Composition on VHL PROTAC Cell Permeability  ACS Publications

Impact of Linker Composition on VHL PROTAC Cell Permeability - ACS Publications

Click here to get full coverage on C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer - ScienceDirect.com

C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer  ScienceDirect.com

C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer - ScienceDirect.com

Click here to get full coverage on Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa - JCI.org

Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa  JCI.org

Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa - JCI.org

Click here to get full coverage on What my sister’s life and death taught me about the NIH - statnews.com

What my sister’s life and death taught me about the NIH  statnews.com

What my sister’s life and death taught me about the NIH - statnews.com

Click here to get full coverage on A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1  Nature

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

Click here to get full coverage on UCLA’s multidisciplinary program transforms the outlook for people with von Hippel-Lindau disease - UCLA Health

UCLA’s multidisciplinary program transforms the outlook for people with von Hippel-Lindau disease  UCLA Health

UCLA’s multidisciplinary program transforms the outlook for people with von Hippel-Lindau disease - UCLA Health

Click here to get full coverage on Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis - PNAS

Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis  PNAS

Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis - PNAS

Click here to get full coverage on Belzutifan Displays Robust Activity in VHL-Associated RCC - OncLive

Belzutifan Displays Robust Activity in VHL-Associated RCC  OncLive

Belzutifan Displays Robust Activity in VHL-Associated RCC - OncLive

Click here to get full coverage on Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan - UroToday

Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan  UroToday

Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan - UroToday

Click here to get full coverage on Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition - Cell Communication and Signaling

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition  Cell Communication and Signaling

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition - Cell Communication and Signaling

Click here to get full coverage on Drugit: crowd-sourcing molecular design of non-peptidic VHL binders - Nature

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders  Nature

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders - Nature

Click here to get full coverage on Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India - Nature

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India  Nature

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India - Nature

Click here to get full coverage on Stick it with VHL - Nature

Stick it with VHL - Nature

Click here to get full coverage on In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID - Nature

In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID  Nature

In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID - Nature

Click here to get full coverage on CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex - Nature

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex  Nature

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex - Nature

Click here to get full coverage on Factors that predict progression of von Hippel-Lindau disease-related malignancy: a longitudinal cohort study - BMC Cancer

Factors that predict progression of von Hippel-Lindau disease-related malignancy: a longitudinal cohort study  BMC Cancer

Factors that predict progression of von Hippel-Lindau disease-related malignancy: a longitudinal cohort study - BMC Cancer

Click here to get full coverage on The Way Forward for the Virtual Health Library After 27 Years - Pan American Health Organization (PAHO)

The Way Forward for the Virtual Health Library After 27 Years  Pan American Health Organization (PAHO)

The Way Forward for the Virtual Health Library After 27 Years - Pan American Health Organization (PAHO)

Click here to get full coverage on A Familial Hematological Pedigree Reveals VHL Germline Mutation as a Principal Predisposition Factor with Additional Mutations Modulating Phenotypic Heterogeneity - Frontiers

A Familial Hematological Pedigree Reveals VHL Germline Mutation as a Principal Predisposition Factor with Additional Mutations Modulating Phenotypic Heterogeneity  Frontiers

A Familial Hematological Pedigree Reveals VHL Germline Mutation as a Principal Predisposition Factor with Additional Mutations Modulating Phenotypic Heterogeneity - Frontiers

Click here to get full coverage on VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway - Nature

VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway  Nature

VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway - Nature

Click here to get full coverage on Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma - ScienceDirect.com

Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma  ScienceDirect.com

Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma - ScienceDirect.com

Click here to get full coverage on Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation - ACS Publications

Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation  ACS Publications

Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation - ACS Publications

Click here to get full coverage on Von Hippel-Lindau (VHL) Disease Market to Reach USD 7.8 Billion by 2034 - openPR.com

Von Hippel-Lindau (VHL) Disease Market to Reach USD 7.8 Billion by 2034  openPR.com

Von Hippel-Lindau (VHL) Disease Market to Reach USD 7.8 Billion by 2034 - openPR.com

Click here to get full coverage on Ternary Complex Modeling, Induced Fit Docking and Molecular Dynamics Simulations as a Successful Approach for the Design of VHL-Mediated PROTACs Targeting the Kinase FLT3 - Wiley Online Library

Ternary Complex Modeling, Induced Fit Docking and Molecular Dynamics Simulations as a Successful Approach for the Design of VHL-Mediated PROTACs Targeting the Kinase FLT3  Wiley Online Library

Ternary Complex Modeling, Induced Fit Docking and Molecular Dynamics Simulations as a Successful Approach for the Design of VHL-Mediated PROTACs Targeting the Kinase FLT3 - Wiley Online Library

Click here to get full coverage on Europe Approves Its First Drug for Von Hippel-Lindau Tumors - Medscape

Europe Approves Its First Drug for Von Hippel-Lindau Tumors  Medscape

Europe Approves Its First Drug for Von Hippel-Lindau Tumors - Medscape

Click here to get full coverage on Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC - BMC Pediatrics

Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC  BMC Pediatrics

Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC - BMC Pediatrics

Click here to get full coverage on Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity - PNAS

Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity  PNAS

Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity - PNAS

Click here to get full coverage on NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs - OncLive

NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs  OncLive

NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs - OncLive

Click here to get full coverage on Suppression of VHL−/− renal carcinoma proliferation by HIF1α.... - researchgate.net

Suppression of VHL−/− renal carcinoma proliferation by HIF1α....  researchgate.net

Suppression of VHL−/− renal carcinoma proliferation by HIF1α.... - researchgate.net

Click here to get full coverage on Fig. 10.2. VCB-CUL2 complex is formed with binding of VHL protein to... - researchgate.net

Fig. 10.2. VCB-CUL2 complex is formed with binding of VHL protein to...  researchgate.net

Fig. 10.2. VCB-CUL2 complex is formed with binding of VHL protein to... - researchgate.net

Click here to get full coverage on VHL & LILACS - Launch of the 2025 Calendar of Meetings with the MedCarib Network - Pan American Health Organization (PAHO)

VHL & LILACS - Launch of the 2025 Calendar of Meetings with the MedCarib Network  Pan American Health Organization (PAHO)

VHL & LILACS - Launch of the 2025 Calendar of Meetings with the MedCarib Network - Pan American Health Organization (PAHO)

Click here to get full coverage on Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC - Nature

Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC  Nature

Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC - Nature

Click here to get full coverage on Laparoscopic Partial Nephrectomy for Multiple Complex Renal Masses in a Patient With Von Hippel-Lindau Syndrome: A Case Report - Cureus

Laparoscopic Partial Nephrectomy for Multiple Complex Renal Masses in a Patient With Von Hippel-Lindau Syndrome: A Case Report  Cureus

Laparoscopic Partial Nephrectomy for Multiple Complex Renal Masses in a Patient With Von Hippel-Lindau Syndrome: A Case Report - Cureus

Click here to get full coverage on Belzutifan Approved for Tumors Linked to VHL - National Cancer Institute (.gov)

Belzutifan Approved for Tumors Linked to VHL  National Cancer Institute (.gov)

Belzutifan Approved for Tumors Linked to VHL - National Cancer Institute (.gov)

Click here to get full coverage on The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet? - ScienceDirect.com

The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet?  ScienceDirect.com

The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet? - ScienceDirect.com

Click here to get full coverage on Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations - Nature

Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations  Nature

Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations - Nature

Click here to get full coverage on Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design - ACS Publications

Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design  ACS Publications

Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design - ACS Publications

Click here to get full coverage on Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders - ScienceDirect.com

Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders  ScienceDirect.com

Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders - ScienceDirect.com

Click here to get full coverage on Saturation genome editing maps the functional spectrum of pathogenic VHL alleles - Nature

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles  Nature

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles - Nature

Click here to get full coverage on Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma  Nature

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature

Click here to get full coverage on VHL mosaicism: the added value of multi-tissue analysis - Nature

VHL mosaicism: the added value of multi-tissue analysis  Nature

VHL mosaicism: the added value of multi-tissue analysis - Nature

Click here to get full coverage on VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells - Cell & Bioscience

VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells  Cell & Bioscience

VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells - Cell & Bioscience

Click here to get full coverage on Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria - NEJM

Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria  NEJM

Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria - NEJM

Click here to get full coverage on Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease - Nature

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease  Nature

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease - Nature

Click here to get full coverage on VHL suppresses UBE3B-mediated breast tumor growth and metastasis | Cell Death & Disease - Nature

VHL suppresses UBE3B-mediated breast tumor growth and metastasis | Cell Death & Disease  Nature

VHL suppresses UBE3B-mediated breast tumor growth and metastasis | Cell Death & Disease - Nature

Click here to get full coverage on Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases - ScienceDirect.com

Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases  ScienceDirect.com

Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases - ScienceDirect.com

Click here to get full coverage on A ‘game-changer’ for von Hippel-Lindau disease treatment - MD Anderson Cancer Center

A ‘game-changer’ for von Hippel-Lindau disease treatment  MD Anderson Cancer Center

A ‘game-changer’ for von Hippel-Lindau disease treatment - MD Anderson Cancer Center

Click here to get full coverage on Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis - Nature

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis  Nature

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis - Nature

Click here to get full coverage on A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs - ScienceDirect.com

A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs  ScienceDirect.com

A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs - ScienceDirect.com

Click here to get full coverage on Louis Robitaille signs with VHL organization for 2025-2026 season - Canadian Hockey League

Louis Robitaille signs with VHL organization for 2025-2026 season  Canadian Hockey League

Louis Robitaille signs with VHL organization for 2025-2026 season - Canadian Hockey League

Click here to get full coverage on Insights into Cullin-RING E3 Ubiquitin Ligase Recruitment: Structure of the VHL-EloBC-Cul2 Complex - ScienceDirect.com

Insights into Cullin-RING E3 Ubiquitin Ligase Recruitment: Structure of the VHL-EloBC-Cul2 Complex  ScienceDirect.com

Vardhman Holdings Limited (VHL)

Price Chart

Key Statistics

Technicals

About VHL

Latest News

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease - Nature

Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study - BioMed Central

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

Advanced Charts

Top Gainers

Top Losers